Oncogenesis driven by the Ras/Raf pathway requires the SUMO E2 ligase Ubc9

Bing Yu(Center for Cancer Research), Ji Luo(Center for Cancer Research)

Proceedings of the National Academy of Sciences

March 24, 2015

10.1073/pnas.1415569112

Cited by 75

Related Papers

A High-Throughput Assay for Small Molecule Destabilizers of the KRAS Oncoprotein

|PLoS ONE|2014|20

A Nonconserved Histidine Residue on KRAS Drives Paralog Selectivity of the KRASG12D Inhibitor MRTX1133

|Cancer Research|2023|19

One-step immortalization of primary human airway epithelial cells capable of oncogenic transformation

|Cell & Bioscience|2016|13

A non-conserved histidine residue on KRAS drives paralog selectivity of the KRAS G12D inhibitor MRTX1133

|bioRxiv (Cold Spring Harbor Laboratory)|2022|1